Showing results (111-120 of 621) with videos related to
Sort By:
Pageof 63
Kidney International|June 1, 1991
Impact of dietary fatty acid supplementation on renal injury in obese Zucker ratsB L Kasiske, M P O'Donnell, H Lee, et al.Mineral and Electrolyte Metabolism|January 1, 1993
The mevalonate pathway: importance in mesangial cell biology and glomerular diseaseM P O'Donnell, B L Kasiske, Y Kim, et al.Kidney International. Supplement|February 1, 1994
Cholesterol synthesis inhibitors inhibit more than cholesterol synthesisB L Kasiske, M P O'Donnell, Y Kim, et al.Kidney International. Supplement|January 4, 1998
Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention TrialR H Grimm, K H Svendsen, B Kasiske, et al.Journal of Clinical Pharmacology|April 1, 1995
Disposition of misoprostol and its active metabolite in patients with normal and impaired renal functionE F Foote, D R Lee, A Karim, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1995
The pharmacokinetics of aminoguanidine in end-stage renal disease patients on hemodialysisE F Foote, Z M Look, P Giles, et al.Journal of the American Society of Nephrology : JASN|April 1, 1993
Alterations in glomerular proteoglycan metabolism in experimental non-insulin dependent diabetes mellitusP Fioretto, W F Keane, B L Kasiske, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1993
Lovastatin retards the progression of established glomerular disease in obese Zucker ratsM P O'Donnell, B L Kasiske, Y Kim, et al.Annals of Internal Medicine|January 15, 1993
Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysisB L Kasiske, R S Kalil, J Z Ma, et al.Kidney International. Supplement|April 1, 1991
Hyperlipidemia and progressive renal diseaseW F Keane, W S Mulcahy, B L Kasiske, et al.Pageof 63